National Surveillance for Pulmonary Arterial Hypertension due to Qing-Dai intake

National Surveillance for Pulmonary Arterial Hypertension due to Qing-Dai intake - National Surveillance for Pulmonary Arterial Hypertension due to Qing-Dai intake

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029453

Enrollment

Registered

2017-10-07

Start date

2017-08-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary arterial hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient of Pulmonary Arterial Hypertension due to Quig-Daiintake

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Clinical characteristics of Pulmonary Arterial Hypertension due to Qing-Dai intake	—

Countries

Japan

Contacts

Public ContactYuichi Tamura

International University of Health and Welfare, Mita Hospital Cardiovascular internal medicine

u1@iuhw.ac.jp03-3451-8121

Outcome results